,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,421,1,3,,17389543,14749,Inconclusive,,,,,Cell Viability - BJ,Confirmatory,,
1,426,1,2,,17389543,14749,Inconclusive,,,,,Cell Viability - Jurkat,Confirmatory,,
2,427,1,1,,17389543,14749,Inconclusive,,,,,Cell Viability - Hek293,Confirmatory,,
3,433,1,1,,17389543,14749,Inconclusive,,,,,Cell Viability - HepG2,Confirmatory,,
4,434,1,2,,17389543,14749,Inconclusive,,,,,Cell Viability - MRC5,Confirmatory,,
5,435,1,2,,17389543,14749,Active,,,,,Cell Viability - SK-N-SH,Confirmatory,,
6,445,3,1,,17389543,14749,Inactive,10092619.0,4792.0,,,IkB Signaling,Confirmatory,,
7,530,1,1,,17389543,14749,Inconclusive,2499604.0,26414.0,,,JNK3 AlphaScreen Assay,Confirmatory,,
8,540,1,1,,17389543,14749,Inconclusive,,,,,Cell Viability - N2a,Confirmatory,,
9,541,1,1,,17389543,14749,Active,,,,,Cell Viability - NIH 3T3,Confirmatory,,
10,542,1,1,,17389543,14749,Active,,,,,Cell Viability - HUV-EC-C,Confirmatory,,
11,543,1,1,,17389543,14749,Inconclusive,,,,,Cell Viability - H-4-II-E,Confirmatory,,
12,544,2,1,,17389543,14749,Inconclusive,,,,,Cell Viability - SH-SY5Y,Confirmatory,,
13,545,1,1,,17389543,14749,Active,,,,,Cell Viability - Renal Proximal Tubule,Confirmatory,,
14,546,1,1,,17389543,14749,Inconclusive,,,,,Cell Viability - Mesenchymal,Confirmatory,,
15,584,1,3,,17389543,14749,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
16,585,1,4,,17389543,14749,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
17,595,1,3,,17389543,14749,Inconclusive,,,,,qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction,Confirmatory,,
18,596,1,2,,17389543,14749,Inactive,92096784.0,4137.0,,,qHTS Assay for Tau Filament Binding,Confirmatory,,
19,603,1,2,,17389543,14749,Inactive,,,,,qHTS Assay for Inhibitors of DNA Polymerase III Holoenzyme System,Confirmatory,,
20,605,1,2,,17389543,14749,Inconclusive,84028058.0,,,,qHTS Assay for Inhibitors of YjeE,Confirmatory,,
21,654,1,1,,17389543,14749,Inactive,,,,,Cellular Toxicity (caspase-3) HepG2,Confirmatory,,
22,655,1,1,,17389543,14749,Inactive,,,,,Cellular Toxicity (caspase-3) Jurkat,Confirmatory,,
23,656,1,1,,17389543,14749,Inactive,,,,,Cellular Toxicity (caspase-3) HUV-EC-C,Confirmatory,,
24,657,1,1,,17389543,14749,Inactive,,,,,Cellular Toxicity (caspase-3) SHSY5Y,Confirmatory,,
25,658,1,1,,17389543,14749,Inactive,,,,,Cellular Toxicity (caspase-3) BJ,Confirmatory,,
26,659,1,1,,17389543,14749,Inactive,,,,,Cellular Toxicity (caspase-3) MRC-5,Confirmatory,,
27,660,1,1,,17389543,14749,Inactive,,,,,Cellular Toxicity (caspase-3) Mesangial,Confirmatory,,
28,661,1,1,,17389543,14749,Inactive,,,,,Cellular Toxicity (caspase-3) SK-N-SH,Confirmatory,,
29,662,1,1,,17389543,14749,Inactive,,,,,Cell signaling CRE-BLA (Fsk stim),Confirmatory,,
30,663,1,1,,17389543,14749,Inactive,,,,,Cellular Toxicity (caspase-3) H-4-II-E,Confirmatory,,
31,664,1,1,,17389543,14749,Inactive,,,,,Cellular Toxicity (caspase-3) Hek293,Confirmatory,,
32,665,1,1,,17389543,14749,Inactive,,,,,Cellular Toxicity (caspase-3) N2a,Confirmatory,,
33,666,1,1,,17389543,14749,Inactive,,,,,Cellular Toxicity (caspase-3) NIH 3T3,Confirmatory,,
34,667,1,1,,17389543,14749,Inactive,,,,,Cellular Toxicity (caspase-3) Renal Proximal Tubule,Confirmatory,,
35,875,1,2,,17389543,14749,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore),Confirmatory,,
36,880,2,1,,17389543,14749,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
37,880,2,1,,17389543,14749,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
38,880,2,1,,29215120,14749,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
39,880,2,1,,29215120,14749,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
40,880,2,1,,50105633,14749,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
41,880,2,1,,50105633,14749,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
42,881,2,2,,17389543,14749,Inactive,317373425.0,247.0,,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
43,881,2,2,,29215120,14749,Inactive,317373425.0,247.0,,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
44,884,1,2,,17389543,14749,Inconclusive,13435386.0,1576.0,10.0,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4,Confirmatory,,
45,885,1,2,,17389543,14749,Inactive,13435386.0,1576.0,10.0,Potency,qHTS Assay for Activators of Cytochrome P450 3A4,Confirmatory,,
46,886,1,2,,17389543,14749,Inconclusive,122921310.0,,0.0794,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
47,886,1,2,,17389543,14749,Inconclusive,122921311.0,,0.0794,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
48,887,1,2,,17389543,14749,Inactive,1832253.0,246.0,,Potency,qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase),Confirmatory,,
49,889,1,3,,17389543,14749,Inactive,1730092.0,840.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
50,892,1,2,,17389543,14749,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore),Confirmatory,,
51,893,1,2,,17389543,14749,Inconclusive,122921310.0,,31.6228,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
52,893,1,2,,17389543,14749,Inconclusive,122921311.0,,31.6228,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
53,894,2,1,,17389543,14749,Active,31542939.0,3248.0,8.9125,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
54,894,2,1,,29215120,14749,Active,31542939.0,3248.0,25.1189,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
55,894,2,1,,50105633,14749,Active,31542939.0,3248.0,17.7828,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
56,900,1,3,,17389543,14749,Inactive,15431328.0,834.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
57,901,1,2,,17389543,14749,Inconclusive,44888968.0,83523.0,3.9811,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors,Confirmatory,,
58,902,1,2,,17389543,14749,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature,Confirmatory,,
59,912,1,2,,17389543,14749,Inactive,21392848.0,,,Potency,qHTS Assay for Anthrax Lethal Toxin Internalization,Confirmatory,,
60,921,1,2,,17389543,14749,Inconclusive,,,31.6228,Potency,Cell Viability - LYMP2-001,Confirmatory,,
61,923,1,2,,17389543,14749,Inactive,,,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region,Confirmatory,,
62,924,1,2,,17389543,14749,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature,Confirmatory,,
63,925,1,2,,17389543,14749,Inactive,4504349.0,3043.0,,Potency,qHTS Assay for Modulators of Hemoglobin Beta Chain Splicing,Confirmatory,,
64,926,1,2,,17389543,14749,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
65,938,1,2,,17389543,14749,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293,Confirmatory,,
66,946,1,2,,17389543,14749,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-001 - Dead Cells,Confirmatory,,
67,947,1,2,,17389543,14749,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-001 - Live Cells,Confirmatory,,
68,948,1,2,,17389543,14749,Inconclusive,,,39.8107,Potency,Cell Viability - LYMP1-002 - Assay at 16 hr,Confirmatory,,
69,955,1,2,,17389543,14749,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Live Cells,Confirmatory,,
70,960,1,2,,17389543,14749,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Dead Cells,Confirmatory,,
71,961,1,2,,17389543,14749,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Dead Cells,Confirmatory,,
72,962,1,2,,17389543,14749,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Live Cells,Confirmatory,,
73,963,1,2,,17389543,14749,Inconclusive,,,39.8107,Potency,Cell Viability - LYMP1-003 - Assay at 24 hr,Confirmatory,,
74,964,1,2,,17389543,14749,Inconclusive,,,39.8107,Potency,Cell Viability - LYMP1-003 - Assay at 40 hr,Confirmatory,,
75,965,1,2,,17389543,14749,Inconclusive,,,25.1189,Potency,Cell Viability - LYMP2-003,Confirmatory,,
76,966,1,2,,17389543,14749,Inconclusive,,,25.1189,Potency,Cell Viability - LYMP2-004,Confirmatory,,
77,967,1,2,,17389543,14749,Inconclusive,,,39.8107,Potency,Cell Viability - LYMP2-005,Confirmatory,,
78,968,1,2,,17389543,14749,Inconclusive,,,39.8107,Potency,Cell Viability - LYMP2-009,Confirmatory,,
79,969,1,2,,17389543,14749,Inconclusive,,,50.1187,Potency,Cell Viability - LYMP2-011,Confirmatory,,
80,970,1,2,,17389543,14749,Inconclusive,,,31.6228,Potency,Cell Viability - LYMP2-013,Confirmatory,,
81,971,1,2,,17389543,14749,Inconclusive,,,39.8107,Potency,Cell Viability - LYMP2-015,Confirmatory,,
82,972,1,2,,17389543,14749,Inconclusive,,,39.8107,Potency,Cell Viability - LYMP2-017,Confirmatory,,
83,973,1,2,,17389543,14749,Inconclusive,,,19.9526,Potency,Cell Viability - LYMP2-019,Confirmatory,,
84,974,1,2,,17389543,14749,Inconclusive,,,39.8107,Potency,Cell Viability - LYMP2-021,Confirmatory,,
85,975,1,2,,17389543,14749,Inconclusive,,,39.8107,Potency,Cell Viability - LYMP2-023,Confirmatory,,
86,976,1,2,,17389543,14749,Inconclusive,,,50.1187,Potency,Cell Viability - LYMP2-025,Confirmatory,,
87,977,1,2,,17389543,14749,Inactive,,,,Potency,Cell Viability - LYMP2-002,Confirmatory,,
88,978,1,2,,17389543,14749,Inconclusive,,,39.8107,Potency,Cell Viability - LYMP2-006,Confirmatory,,
89,979,1,2,,17389543,14749,Inconclusive,,,39.8107,Potency,Cell Viability - LYMP2-007,Confirmatory,,
90,980,1,2,,17389543,14749,Inconclusive,,,39.8107,Potency,Cell Viability - LYMP2-008,Confirmatory,,
91,981,1,2,,17389543,14749,Inconclusive,,,50.1187,Potency,Cell Viability - LYMP2-010,Confirmatory,,
92,982,1,2,,17389543,14749,Inconclusive,,,19.9526,Potency,Cell Viability - LYMP2-012,Confirmatory,,
93,983,1,2,,17389543,14749,Inconclusive,,,39.8107,Potency,Cell Viability - LYMP2-014,Confirmatory,,
94,984,1,2,,17389543,14749,Inconclusive,,,50.1187,Potency,Cell Viability - LYMP2-016,Confirmatory,,
95,985,1,2,,17389543,14749,Inconclusive,,,39.8107,Potency,Cell Viability - LYMP2-018,Confirmatory,,
96,986,1,2,,17389543,14749,Inactive,,,,Potency,Cell Viability - LYMP2-020,Confirmatory,,
97,987,1,2,,17389543,14749,Inconclusive,,,39.8107,Potency,Cell Viability - LYMP2-022,Confirmatory,,
98,988,1,2,,17389543,14749,Inconclusive,,,39.8107,Potency,Cell Viability - LYMP2-024,Confirmatory,,
99,989,1,2,,17389543,14749,Inconclusive,,,39.8107,Potency,Cell Viability - LYMP2-026,Confirmatory,,
100,993,1,2,,17389543,14749,Inconclusive,,,39.8107,Potency,Cell Viability - LYMP1-002 - Assay at 24 hr,Confirmatory,,
101,994,1,2,,17389543,14749,Inconclusive,,,39.8107,Potency,Cell Viability - LYMP1-002 - Assay at 40 hr,Confirmatory,,
102,995,1,2,,17389543,14749,Inconclusive,66932916.0,5594.0,3.9811,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay,Confirmatory,,
103,1030,2,1,,17389543,14749,Inconclusive,30582681.0,216.0,4.4668,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
104,1030,2,1,,29215120,14749,Inconclusive,30582681.0,216.0,39.8107,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
105,1030,2,1,,50105633,14749,Active,30582681.0,216.0,11.2202,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
106,1379,1,2,,29215120,14749,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
107,1379,1,2,,50105633,14749,Active,1669525.0,,12.5893,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
108,1452,1,1,,17389543,14749,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
109,1452,1,1,,29215120,14749,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
110,1454,1,1,,50105633,14749,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
111,1457,1,1,,17389543,14749,Inactive,44888968.0,83523.0,28.1838,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
112,1457,1,1,,29215120,14749,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
113,1457,1,1,,50105633,14749,Inactive,44888968.0,83523.0,28.1838,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
114,1458,1,1,,17389543,14749,Inactive,10937869.0,6607.0,15.8489,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
115,1460,1,3,,29215120,14749,Inconclusive,92096784.0,4137.0,14.1254,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
116,1460,1,3,,50105633,14749,Inconclusive,92096784.0,4137.0,28.1838,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
117,1463,1,1,,29215120,14749,Inactive,,,,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
118,1463,1,1,,50105633,14749,Inconclusive,,,31.6228,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
119,1467,1,3,,29215120,14749,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
120,1467,1,3,,50105633,14749,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
121,1468,1,1,,29215120,14749,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
122,1468,1,1,,50105633,14749,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
123,1469,1,1,,17389543,14749,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
124,1469,1,1,,29215120,14749,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
125,1469,1,1,,50105633,14749,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
126,1471,2,1,,17389543,14749,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
127,1471,2,1,,29215120,14749,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
128,1471,2,1,,50105633,14749,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
129,1476,2,1,,17389543,14749,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
130,1476,2,1,,29215120,14749,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
131,1476,2,1,,50105633,14749,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
132,1477,1,1,,17389543,14749,Inconclusive,,,7.9433,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
133,1477,1,1,,50105633,14749,Inconclusive,,,15.8489,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
134,1478,2,1,,17389543,14749,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
135,1478,2,1,,29215120,14749,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
136,1478,2,1,,50105633,14749,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
137,1479,1,2,,17389543,14749,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
138,1479,1,2,,29215120,14749,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
139,1479,1,2,,50105633,14749,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
140,1487,1,1,,29215120,14749,Inactive,27436948.0,4000.0,,Potency,qHTS Assay for Modulators of Lamin A Splicing,Confirmatory,,
141,1490,2,1,,29215120,14749,Inconclusive,10954339.0,,19.9526,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
142,1490,2,1,,50105633,14749,Inconclusive,10954339.0,,79.4328,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
143,1519,1,3,,50105633,14749,Inconclusive,,,10.0,Potency,qHTS Assay for Lipid Storage Modulators,Confirmatory,,
144,1688,1,1,,29215120,14749,Inactive,90903231.0,3064.0,,Potency,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP),Confirmatory,,
145,1766,1,1,,29215120,14749,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
146,1766,1,1,,29215120,14749,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
147,1766,1,1,,50105633,14749,Inconclusive,18860839.0,4221.0,39.8107,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
148,1766,1,1,,50105633,14749,Inconclusive,56550039.0,4297.0,39.8107,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
149,1768,1,1,,29215120,14749,Inconclusive,18860839.0,4221.0,39.8107,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
150,1768,1,1,,29215120,14749,Inconclusive,56550039.0,4297.0,39.8107,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
151,1768,1,1,,50105633,14749,Inconclusive,18860839.0,4221.0,10.0,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
152,1768,1,1,,50105633,14749,Inconclusive,56550039.0,4297.0,10.0,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
153,1865,1,1,,29215120,14749,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
154,1865,1,1,,50105633,14749,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
155,1948,1,1,,17389543,14749,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
156,1948,1,1,,29215120,14749,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
157,1948,1,1,,50105633,14749,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
158,2101,1,1,,17389543,14749,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
159,2101,1,1,,29215120,14749,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
160,2101,1,1,,50105633,14749,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
161,2107,1,1,,17389543,14749,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
162,2107,1,1,,29215120,14749,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
163,2107,1,1,,50105633,14749,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
164,2112,1,1,,17389543,14749,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
165,2112,1,1,,29215120,14749,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
166,2112,1,1,,50105633,14749,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
167,2120,1,1,,17389543,14749,Inactive,32879895.0,3091.0,,Potency,qHTS Assay for Identification of Small Molecule Inducers of Hypoxia Response,Confirmatory,,
168,2147,1,1,,50105633,14749,Active,221046486.0,,7.9433,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
169,2314,1,2,,29215120,14749,Inactive,32400299.0,,,,Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin,Screening,,
170,2314,1,2,,29215120,14749,Inactive,32400300.0,,,,Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin,Screening,,
171,2315,1,2,,29215120,14749,Inactive,32400299.0,,,,A qHTS for Small Molecule Inhibitors of Shiga Toxin,Screening,,
172,2315,1,2,,29215120,14749,Inactive,32400300.0,,,,A qHTS for Small Molecule Inhibitors of Shiga Toxin,Screening,,
173,2451,1,2,,29215120,14749,Active,122920737.0,,22.3342,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
174,2451,1,2,,50105633,14749,Active,122920737.0,,17.7407,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
175,2472,1,2,,29215120,14749,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
176,2472,1,2,,50105633,14749,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
177,2517,2,1,,17389543,14749,Inconclusive,6980812.0,,28.1838,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
178,2517,2,1,,50105633,14749,Active,6980812.0,,10.0,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
179,2528,1,2,,29215120,14749,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
180,2528,1,2,,50105633,14749,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
181,2546,1,1,,17389543,14749,Inconclusive,188536040.0,19885.0,11.2202,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
182,2546,1,1,,29215120,14749,Inconclusive,188536040.0,19885.0,14.1254,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
183,2546,1,1,,50105633,14749,Inconclusive,188536040.0,19885.0,14.1254,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
184,2549,1,1,,17389543,14749,Active,282403581.0,,25.1189,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
185,2549,1,1,,29215120,14749,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
186,2549,1,1,,50105633,14749,Active,282403581.0,,31.6228,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
187,2551,1,1,,17389543,14749,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
188,2551,1,1,,29215120,14749,Inconclusive,188536040.0,19885.0,15.8489,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
189,2551,1,1,,50105633,14749,Inconclusive,188536040.0,19885.0,17.7828,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
190,2564,1,1,,29215120,14749,Inconclusive,,,11.2202,Potency,Counterscreen for APE1 Inhibitors: Fluorescent Dye Displacement Assay,Confirmatory,,
191,2565,1,1,,29215120,14749,Inactive,405898.0,,,Potency,Counterscreen for APE1 Inhibitors: qHTS Assay for Inhibitors of Endonuclease IV,Confirmatory,,
192,2572,1,1,,29215120,14749,Active,6980812.0,,3.1623,Potency,Confirmation qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
193,2573,1,1,,29215120,14749,Inconclusive,6980812.0,,11.2202,Potency,qHTS FP-Based Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
194,2662,2,1,,29215120,14749,Inactive,56550039.0,4297.0,,Potency,qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction,Confirmatory,,
195,99424,8,2,,163319227,14749,Unspecified,,,1000.0,IC50,Inhibition of human Leukocyte Antigen Related(LAR) protein tyrosine phosphatase D1,Confirmatory,15050628.0,
196,157217,10,5,,163319227,14749,Active,131467.0,5770.0,26.0,IC50,Inhibition of human PTPase 1B,Confirmatory,15050628.0,
197,220230,9,5,,163319227,14749,Active,131557.0,851368.0,15.0,IC50,Inhibitory activity against Saccharomyces cerevisiae Tyrosine phosphatase 1,Confirmatory,15050628.0,
198,485281,1,1,,29215120,14749,Inactive,254220970.0,,,Potency,qHTS Assay for Identification of Novel General Anesthetics,Confirmatory,,
199,485290,1,1,,17389543,14749,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
200,485290,1,1,,29215120,14749,Active,20150581.0,,0.7079,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
201,485290,1,1,,50105633,14749,Inconclusive,20150581.0,,1.9953,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
202,489007,1,1,,29215120,14749,Inconclusive,20150581.0,,6.3096,Potency,Confirmation Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
203,489007,1,1,,50105633,14749,Inconclusive,20150581.0,,15.8489,Potency,Confirmation Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
204,492961,1,1,,29215120,14749,Inactive,72386991.0,3656265.0,,Potency,qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase: hit validation,Confirmatory,,
205,504327,1,1,,29215120,14749,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
206,504327,1,1,,50105633,14749,Inconclusive,153791535.0,2648.0,39.8107,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
207,504332,1,1,,29215120,14749,Active,168985070.0,,7.0795,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
208,504749,1,3,,29215120,14749,Unspecified,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
209,504749,1,3,1.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
210,504749,1,3,2.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
211,504749,1,3,3.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
212,504749,1,3,4.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
213,504749,1,3,5.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
214,504749,1,3,6.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
215,504749,1,3,7.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
216,504749,1,3,8.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
217,504749,1,3,9.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
218,504749,1,3,10.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
219,504749,1,3,11.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
220,504749,1,3,12.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
221,504749,1,3,13.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
222,504749,1,3,14.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
223,504749,1,3,15.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
224,504749,1,3,16.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
225,504749,1,3,17.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
226,504749,1,3,18.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
227,504749,1,3,19.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
228,504749,1,3,20.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
229,504749,1,3,21.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
230,504749,1,3,22.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
231,504749,1,3,23.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
232,504749,1,3,24.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
233,504749,1,3,25.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
234,504749,1,3,26.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
235,504749,1,3,27.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
236,504749,1,3,28.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
237,504749,1,3,29.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
238,504749,1,3,30.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
239,504749,1,3,31.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
240,504749,1,3,32.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
241,504749,1,3,33.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
242,504749,1,3,34.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
243,504749,1,3,35.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
244,504749,1,3,36.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
245,504749,1,3,37.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
246,504749,1,3,38.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
247,504749,1,3,39.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
248,504749,1,3,40.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
249,504749,1,3,41.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
250,504749,1,3,42.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
251,504749,1,3,43.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
252,504749,1,3,44.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
253,504749,1,3,45.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
254,504749,1,3,46.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
255,504749,1,3,47.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
256,504749,1,3,48.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
257,504749,1,3,49.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
258,504749,1,3,50.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
259,504749,1,3,51.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
260,504749,1,3,52.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
261,504749,1,3,53.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
262,504749,1,3,54.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
263,504749,1,3,55.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
264,504749,1,3,56.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
265,504749,1,3,57.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
266,504749,1,3,58.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
267,504749,1,3,59.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
268,504749,1,3,60.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
269,504749,1,3,61.0,29215120,14749,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
270,504832,1,1,,29215120,14749,Inactive,,,,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation",Confirmatory,,
271,504834,1,1,,29215120,14749,Inconclusive,,,6.0120000000000005,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation",Confirmatory,,
272,504845,1,1,,50105633,14749,Inactive,86301163.0,5999.0,,Potency,Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS,Confirmatory,,
273,504847,1,1,,29215120,14749,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
274,504847,1,1,,50105633,14749,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
275,504865,1,1,,29215120,14749,Inconclusive,118600387.0,7398.0,56.2341,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
276,504865,1,1,,50105633,14749,Inconclusive,118600387.0,7398.0,56.2341,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
277,588379,1,2,,50105633,14749,Inactive,13399304.0,60489.0,,Potency,qHTS for inhibitors of Vif-A3G interactions: Validation,Confirmatory,,
278,588453,1,1,,124891285,14749,Inconclusive,8659577.0,58819.0,50.1187,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
279,588456,1,1,,124891285,14749,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
280,588513,1,1,,17389543,14749,Inactive,348019627.0,2099.0,,Potency,qHTS assay for small molecule antagonists of estrogen receptor alpha signaling,Confirmatory,,
281,588514,1,1,,17389543,14749,Inactive,348019627.0,2099.0,,Potency,qHTS assay for small molecule agonists of estrogen receptor alpha signaling,Confirmatory,,
282,588515,1,1,,17389543,14749,Inactive,124375976.0,367.0,,Potency,qHTS assay for small molecule agonists of androgen receptor signaling,Confirmatory,,
283,588516,1,1,,17389543,14749,Inactive,124375976.0,367.0,,Potency,qHTS assay for small molecule antagonists of androgen receptor signaling,Confirmatory,,
284,588526,1,1,,17389543,14749,Inactive,325495553.0,9971.0,,Potency,qHTS assay for small molecule antagonists of farnesoid X receptor signaling,Confirmatory,,
285,588527,1,1,,17389543,14749,Inactive,325495553.0,9971.0,,Potency,qHTS assay for small molecule agonists of farnesoid X receptor signaling,Confirmatory,,
286,588532,1,1,,17389543,14749,Inactive,311348376.0,2908.0,,Potency,qHTS assay for small molecule agonists of glucocorticoid receptor signaling,Confirmatory,,
287,588533,1,1,,17389543,14749,Inactive,311348376.0,2908.0,,Potency,qHTS assay for small molecule antagonists of glucocorticoid receptor signaling,Confirmatory,,
288,588534,1,1,,17389543,14749,Inactive,216409690.0,5467.0,,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
289,588535,1,1,,17389543,14749,Inactive,216409690.0,5467.0,,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
290,588536,1,1,,17389543,14749,Inactive,216409692.0,5468.0,,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
291,588537,1,1,,17389543,14749,Inconclusive,216409692.0,5468.0,,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
292,588541,1,1,,17389543,14749,Inactive,216409708.0,7421.0,,Potency,qHTS assay for small molecule antagonists of vitamin D receptor signaling,Confirmatory,,
293,588543,1,1,,17389543,14749,Inactive,216409708.0,7421.0,,Potency,qHTS assay for small molecule agonists of vitamin D receptor signaling,Confirmatory,,
294,588544,1,1,,17389543,14749,Inactive,325495497.0,6256.0,,Potency,qHTS assay for small molecule agonists of retinoid X receptor alpha signaling,Confirmatory,,
295,588545,1,1,,17389543,14749,Inactive,189491771.0,7068.0,,Potency,qHTS assay for small molecule agonists of thyroid hormone receptor beta signaling,Confirmatory,,
296,588546,1,1,,17389543,14749,Inactive,325495497.0,6256.0,,Potency,qHTS assay for small molecule antagonists of retinoid X receptor alpha signaling,Confirmatory,,
297,588547,1,1,,17389543,14749,Inconclusive,189491771.0,7068.0,0.0355,Potency,qHTS assay for small molecule antagonists of thyroid hormone receptor beta signaling,Confirmatory,,
298,588579,1,1,,29215120,14749,Active,7705344.0,51426.0,8.4368,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
299,588579,1,1,,50105633,14749,Active,7705344.0,51426.0,3.1623,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
300,588579,1,1,,124891285,14749,Active,7705344.0,51426.0,19.9526,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
301,588590,1,1,,124891285,14749,Active,154350220.0,11201.0,79.4328,Potency,qHTS for Inhibitors of Polymerase Iota,Confirmatory,,
302,588795,1,1,,124891285,14749,Active,4758356.0,2237.0,50.1187,Potency,qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1).,Confirmatory,,
303,588812,1,1,,17389543,14749,Unspecified,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
304,588812,1,1,1.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
305,588812,1,1,2.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
306,588812,1,1,3.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
307,588812,1,1,4.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
308,588812,1,1,5.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
309,588812,1,1,6.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
310,588812,1,1,7.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
311,588812,1,1,8.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
312,588812,1,1,9.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
313,588812,1,1,10.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
314,588812,1,1,11.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
315,588812,1,1,12.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
316,588812,1,1,13.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
317,588812,1,1,14.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
318,588812,1,1,15.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
319,588812,1,1,16.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
320,588812,1,1,17.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
321,588812,1,1,18.0,17389543,14749,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
322,588812,1,1,19.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
323,588812,1,1,20.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
324,588812,1,1,21.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
325,588812,1,1,22.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
326,588812,1,1,23.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
327,588812,1,1,24.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
328,588812,1,1,25.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
329,588812,1,1,26.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
330,588812,1,1,27.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
331,588812,1,1,28.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
332,588812,1,1,29.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
333,588812,1,1,30.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
334,588812,1,1,31.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
335,588812,1,1,32.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
336,588812,1,1,33.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
337,588812,1,1,34.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
338,588812,1,1,35.0,17389543,14749,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
339,588812,1,1,36.0,17389543,14749,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
340,588812,1,1,37.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
341,588812,1,1,38.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
342,588812,1,1,39.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
343,588812,1,1,40.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
344,588812,1,1,41.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
345,588812,1,1,42.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
346,588812,1,1,43.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
347,588812,1,1,44.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
348,588812,1,1,45.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
349,588812,1,1,46.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
350,588812,1,1,47.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
351,588812,1,1,48.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
352,588812,1,1,49.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
353,588812,1,1,50.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
354,588812,1,1,51.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
355,588812,1,1,52.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
356,588812,1,1,53.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
357,588812,1,1,54.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
358,588812,1,1,55.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
359,588812,1,1,56.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
360,588812,1,1,57.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
361,588812,1,1,58.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
362,588812,1,1,59.0,17389543,14749,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
363,588812,1,1,60.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
364,588812,1,1,61.0,17389543,14749,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
365,588812,1,1,62.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
366,588812,1,1,63.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
367,588812,1,1,64.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
368,588812,1,1,65.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
369,588812,1,1,66.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
370,588812,1,1,67.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
371,588812,1,1,68.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
372,588812,1,1,69.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
373,588812,1,1,70.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
374,588812,1,1,71.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
375,588812,1,1,72.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
376,588812,1,1,73.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
377,588812,1,1,74.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
378,588812,1,1,75.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
379,588812,1,1,76.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
380,588812,1,1,77.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
381,588812,1,1,78.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
382,588812,1,1,79.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
383,588812,1,1,80.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
384,588812,1,1,81.0,17389543,14749,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
385,588813,1,1,,17389543,14749,Unspecified,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
386,588813,1,1,1.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
387,588813,1,1,2.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
388,588813,1,1,3.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
389,588813,1,1,4.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
390,588813,1,1,5.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
391,588813,1,1,6.0,17389543,14749,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
392,588813,1,1,7.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
393,588813,1,1,8.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
394,588813,1,1,9.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
395,588813,1,1,10.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
396,588813,1,1,11.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
397,588813,1,1,12.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
398,588813,1,1,13.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
399,588813,1,1,14.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
400,588813,1,1,15.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
401,588813,1,1,16.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
402,588813,1,1,17.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
403,588813,1,1,18.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
404,588813,1,1,19.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
405,588813,1,1,20.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
406,588813,1,1,21.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
407,588813,1,1,22.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
408,588813,1,1,23.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
409,588813,1,1,24.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
410,588813,1,1,25.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
411,588813,1,1,26.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
412,588813,1,1,27.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
413,588813,1,1,28.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
414,588813,1,1,29.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
415,588813,1,1,30.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
416,588813,1,1,31.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
417,588813,1,1,32.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
418,588813,1,1,33.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
419,588813,1,1,34.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
420,588813,1,1,35.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
421,588813,1,1,36.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
422,588813,1,1,37.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
423,588813,1,1,38.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
424,588813,1,1,39.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
425,588813,1,1,40.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
426,588813,1,1,41.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
427,588813,1,1,42.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
428,588813,1,1,43.0,17389543,14749,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
429,588813,1,1,44.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
430,588813,1,1,45.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
431,588813,1,1,46.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
432,588813,1,1,47.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
433,588813,1,1,48.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
434,588813,1,1,49.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
435,588813,1,1,50.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
436,588813,1,1,51.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
437,588813,1,1,52.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
438,588813,1,1,53.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
439,588813,1,1,54.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
440,588813,1,1,55.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
441,588813,1,1,56.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
442,588813,1,1,57.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
443,588813,1,1,58.0,17389543,14749,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
444,588813,1,1,59.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
445,588813,1,1,60.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
446,588813,1,1,61.0,17389543,14749,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
447,588813,1,1,62.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
448,588813,1,1,63.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
449,588813,1,1,64.0,17389543,14749,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
450,588813,1,1,65.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
451,588813,1,1,66.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
452,588813,1,1,67.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
453,588813,1,1,68.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
454,588813,1,1,69.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
455,588813,1,1,70.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
456,588813,1,1,71.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
457,588813,1,1,72.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
458,588813,1,1,73.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
459,588813,1,1,74.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
460,588813,1,1,75.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
461,588813,1,1,76.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
462,588813,1,1,77.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
463,588813,1,1,78.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
464,588813,1,1,79.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
465,588813,1,1,80.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
466,588813,1,1,81.0,17389543,14749,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
467,588834,2,1,,17389543,14749,Inconclusive,325651834.0,3757.0,79.4328,Potency,qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity,Confirmatory,,
468,588855,1,1,,124891285,14749,Inactive,18418623.0,4088.0,,Potency,qHTS for Inhibitors of TGF-b,Confirmatory,,
469,588856,1,1,,124891285,14749,Inactive,,,,Potency,qHTS for Inhibitors of TGF-b: Cytotox Counterscreen,Confirmatory,,
470,602310,1,2,,124891285,14749,Inactive,13399304.0,60489.0,,Potency,qHTS for Inhibitors of Vif-A3G Interactions: qHTS,Confirmatory,,
471,602332,1,1,,29215120,14749,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
472,602332,1,1,,50105633,14749,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
473,602332,1,1,,124891285,14749,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
474,624030,1,2,,29215120,14749,Inconclusive,160794.0,,14.3818,Potency,Biochemical firefly luciferase enzyme assay for NPC,Confirmatory,,
475,624031,1,2,,29215120,14749,Inconclusive,,,36.1254,Potency,S16 Schwann cell viability assay (CellTiter-Glo assay),Confirmatory,,
476,624032,1,2,,29215120,14749,Inconclusive,8393992.0,24660.0,22.7936,Potency,S16 Schwann cell PMP22 intronic element firefly luciferase assay,Confirmatory,,
477,624044,1,2,,29215120,14749,Inactive,8393992.0,24660.0,,Potency,S16 Schwann cell PMP22 intronic element beta-lactamase assay,Confirmatory,,
478,624170,1,1,,29215120,14749,Inconclusive,71051501.0,2744.0,17.7828,Potency,qHTS for Inhibitors of Glutaminase (GLS),Confirmatory,,
479,624172,1,1,,29215120,14749,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists,Confirmatory,,
480,624173,1,3,,29215120,14749,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
481,624178,1,1,,124891285,14749,Unspecified,179095.0,6609.0,,Potency,qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate,Confirmatory,,
482,624202,1,1,,124891285,14749,Inactive,1698399.0,672.0,,Potency,qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression,Confirmatory,,
483,624263,1,1,,124891285,14749,Inactive,3063388.0,5071.0,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
484,624263,1,1,,124891285,14749,Inactive,37183032.0,,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
485,624296,1,1,,29215120,14749,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
486,624297,1,1,,29215120,14749,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
487,624414,1,1,,124891285,14749,Inactive,10092597.0,57192.0,,,qHTS for Agonists of the Human Mucolipin Transient Receptor Potential 1 (TRPML1),Screening,,
488,651741,1,1,,17389543,14749,Inactive,20149576.0,4780.0,,Potency,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
489,651743,1,1,,17389543,14749,Inactive,269849759.0,7157.0,,Potency,qHTS assay for small molecule activators of the p53 signaling pathway,Confirmatory,,
490,651749,1,1,,17389543,14749,Inactive,34577122.0,4790.0,,Potency,qHTS assay for small molecule activators of the nuclear factor-kappa B (NF-kB) signaling pathway,Confirmatory,,
491,651751,1,1,,17389543,14749,Inactive,5702233.0,84385.0,,Potency,qHTS assay for small molecule activators of the rat pregnane X receptor (rPXR) signaling pathway,Confirmatory,,
492,651754,1,1,,17389543,14749,Inactive,,,,Potency,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 1 hr assay,Confirmatory,,
493,651755,1,1,,17389543,14749,Inactive,,,,Potency,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 5 hr assay,Confirmatory,,
494,651757,1,1,,17389543,14749,Inconclusive,25952111.0,7124.0,,Potency,qHTS assay to identify small molecules that stimulate Tumor Necrosis Factor-alpha (TNF-alpha) secretion,Confirmatory,,
495,651758,1,1,,17389543,14749,Inconclusive,186368.0,3576.0,74.97800000000001,Potency,qHTS assay to identify small molecules that stimulate interleukin-8 (IL-8) secretion,Confirmatory,,
496,651777,1,1,,17389543,14749,Inactive,51095037.0,196.0,,Potency,qHTS assay for environmental chemicals that activate the Aryl hydrocarbon Receptor (AhR) signaling pathway,Confirmatory,,
497,651778,1,1,,17389543,14749,Inactive,3041727.0,5465.0,,Potency,qHTS assay for small molecule agonists of the peroxisome proliferator-activated receptor alpha (PPARalpha) signaling pathway,Confirmatory,,
498,651802,1,1,,17389543,14749,Active,49066040.0,6097.0,26.6032,Potency,qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
499,651838,1,1,,17389543,14749,Unspecified,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
500,651838,1,1,1.0,17389543,14749,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
501,651838,1,1,2.0,17389543,14749,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
502,651838,1,1,3.0,17389543,14749,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
503,651838,1,1,4.0,17389543,14749,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
504,651838,1,1,5.0,17389543,14749,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
505,651838,1,1,6.0,17389543,14749,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
506,651838,1,1,7.0,17389543,14749,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
507,651838,1,1,8.0,17389543,14749,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
508,651965,1,1,,124891285,14749,Inactive,2668494.0,,,Potency,qHTS Assay for Activators of ClpP,Confirmatory,,
509,652106,1,1,,124891285,14749,Inactive,586067.0,6622.0,11.2202,Potency,qHTS of alpha-syn Inhibitors,Confirmatory,,
510,686978,1,1,,50105633,14749,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
511,686978,1,1,,124891285,14749,Inconclusive,79154014.0,55775.0,11.2202,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
512,686979,1,1,,50105633,14749,Inconclusive,79154014.0,55775.0,5.9569,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
513,686979,1,1,,124891285,14749,Active,79154014.0,55775.0,8.9125,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
514,720532,1,1,,50105633,14749,Inactive,420597.0,,,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
515,720533,1,1,,50105633,14749,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
516,720540,1,1,,124891285,14749,Active,26667227.0,2139.0,16.9469,Potency,qHTS for Inhibitors of the Phosphatase Activity of Eya2: Confirmatory Assay for Cherry-picked Compounds,Confirmatory,,
517,720541,1,1,,124891285,14749,Active,6014741.0,1487.0,19.0148,Potency,qHTS for Inhibitors of the Phosphatase Activity of Eya2: Carboxyl-terminal binding protein (CtBP) Counterscreen for Cherry-picked Compounds,Confirmatory,,
518,720579,2,1,,124891285,14749,Inactive,222762.0,3707576.0,10.0,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS,Confirmatory,,
519,720580,1,1,,124891285,14749,Inactive,222762.0,3707576.0,10.0,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS,Confirmatory,,
520,720636,1,1,,17389543,14749,Inactive,20149576.0,4780.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity,Confirmatory,,
521,720652,1,1,,17389543,14749,Inconclusive,,,37.578,Potency-Replicate_1,qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
522,720653,1,1,,17389543,14749,Inconclusive,,,35.4813,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity - cell viability counter screen,Confirmatory,,
523,720659,1,1,,17389543,14749,Inactive,325495557.0,8856.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the human pregnane X receptor (PXR) signaling pathway,Confirmatory,,
524,743288,1,1,,17389543,14749,Inconclusive,,,31.6228,Potency,qHTS assay for cell viability of HEK293 cells,Confirmatory,,
525,743292,1,1,,17389543,14749,Active,,,44.6684,Potency,qHTS assay for cell viability of the p53RE-bla HCT-116 cell line,Confirmatory,,
526,1259310,1,1,,321949434,14749,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
527,1259389,1,1,,175607832,14749,Active,,,,,HIV1_TAR : FRET assay measuring displacement of FAM and TAMRA-labeled Tat peptide from HIV-1 TAR RNA.,Screening,,
